Clinical Trials Browser

OTHER × Glioblastoma × TPI-287 × Clear all

NCT01582152 2019-06-05

Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma

Phase 1/2 Terminated

12 enrolled 7 charts

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT01113463 2016-10-31

TPI 287 in Patients With Recurrent Glioblastoma Multiforme

Phase 2 Terminated

17 enrolled 3 charts

Brain Neoplasms, Glioblastoma